Reducing SNAP benefits will leave families struggling to afford food and household expenses, says study

According to Instagram, Bieber counts the multitasking formula among her empties.View Entire Post ›

“I don’t know that I have ever heard a celebrity talk about a hot flash in the moment. Thank you for being so real.”View Entire Post ›

The Embryolisse Lait-Crème Concentré is a multi-tasking hidden gem of a facial cream.View Entire Post ›

After the model opened up about her experience being diagnosed with type 1 diabetes, we asked experts about the autoimmune condition, the differences between type 1 and type 2 diabetes, and how this diagnosis can change your life.View Entire Post ›

An acupuncturist explains how this scary-looking acupressure mat can help relieve back pain.View Entire Post ›

The approval of new antibody medications for Alzheimer's disease—lecanemab and donanemab—and diagnostic tests in the blood mark the beginning of a new era in Alzheimer's disease diagnosis and treatment. However, without rapid reform in health care systems, public policy, and societal attitudes, their potential will not be fully realized, argue 40 leading Alzheimer's disease experts in The Lancet Series on Alzheimer's disease.

A difference-in-differences analysis examined hospital staffing and patient outcomes after private equity acquisition, focusing on emergency departments (EDs) and intensive care units (ICUs).

A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative breast and urothelial bladder cancers within four hours, according to research published in the Journal of Nuclear Medicine. This same-day imaging approach has the potential to save valuable time in guiding treatment decisions and reduce unnecessary exposure to ineffective therapies.

For undergraduates, a trip to the dentist can reflect more than oral health. Those who kept up with dental exams were also more likely to schedule eye and physical exams, carry health insurance, and rate their overall health more positively, according to a recent study.

The trillions of microbes that live in the human gut may play a bigger role in health than previously thought, according to new research by the University of Hawaiʻi at Mānoa. The article, published in the International Journal of Molecular Sciences, explores how gut bacteria interact with human genes in ways that could shape disease risk, aging and even future medical treatments.

Periodic limb movements (PLMs) occur frequently among persons with epilepsy (PWE) but do not occur more often than among those with obstructive sleep apnea (OSA), according to a study published in Epilepsy Research.

A potentially life-saving device has been developed for new mothers in high-risk settings. This low-cost medical device to stop postpartum hemorrhages is the result of the BAMBI (Balloon Against Maternal BleedIng) project conducted by a multidisciplinary research team at the Politecnico di Milano. It is now ready for the final phase of testing, namely clinical trials on patients.

Nearly two-thirds of Americans diagnosed with Alzheimer's disease are women, and they often experience faster cognitive decline than men. The reasons behind this sex gap have largely remained a mystery—until now.

Researchers at the University of Toronto have discovered that bacteria can drive stem cell regeneration to repair the intestinal lining after injury—uncovering an unexpected way in which the gut microbiome contributes to human health.

Hidden in plain sight, dried fish are an overlooked yet vital nutrient-packed superfood helping to feed millions of people across Africa, a new study reveals.

A new study shows that the widely used antidepressant fluoxetine does more than boost serotonin levels: it changes how brain cells manage their energy and rebuild their connections, potentially helping the brain "loosen up" and adapt during depression treatment.

People who receive regular phone support after losing weight are more likely to keep the pounds off—but getting extra calls when at risk of regaining weight doesn't provide additional benefit, according to a new study led by Kathryn M. Ross, Ph.D., M.P.H., senior research scientist at Advocate Aurora Research Institute and associate professor in the Department of Social Sciences and Health Policy at Wake Forest University School of Medicine.

Through a comprehensive approach combining transcriptomic profiling, histological analysis, and functional validation in organoid and animal models, a research team led by Associate Professor Yoshinori Yoshida and Assistant Professor Shunsuke Funakoshi has identified fibroblast growth factor receptor 1 (FGFR1) as a key therapeutic target for cardiac fibrosis in dilated cardiomyopathy (DCM).